Hunan Er-Kang Pharmaceutical Co.,Ltd.’s Net Profit Rose 3.4% in First Quarter of 2023

Hunan Er-Kang Pharmaceutical Co.,Ltd. (湖南尔康制药股份有限公司) (300267.SZ) reported a net profit of 20.5 million yuan in the first quarter of 2023, up 3.4% year-on-year.

Meanwhile, the company posted 546.9 million yuan in revenue, up 28.3% year-on-year.

At the end of the reporting period, it had 5.6 billion yuan in total assets and 551.6 million yuan in total liabilities, with a liability-to-asset ratio of 9.9%.